Form 8-K - Current report:
SEC Accession No. 0001411690-25-000003
Filing Date
2025-01-13
Accepted
2025-01-13 16:11:06
Documents
17
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20250113.htm   iXBRL 8-K 30090
2 EX-99.1 bionano-q42024earningsprer.htm EX-99.1 39737
6 image_2.jpg GRAPHIC 45857
7 picture3a.jpg GRAPHIC 3015
8 picture4a.jpg GRAPHIC 1947
  Complete submission text file 0001411690-25-000003.txt   274680

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20250113.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20250113_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20250113_pre.xml EX-101.PRE 12516
19 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20250113_htm.xml XML 2732
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25526490
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)